In contrast, EMPA therapy demonstrated protective effects against Aβ-mediated neuronal damage and plaque formation in SCO/HMM-induced AD rats, accompanied by a reduction in BACE1 levels. The gene discussed is BACE1; the disease is Alzheimer disease.